Report cover image

Global IVD In Cardiology and Neurology Market Size- By Product Type, By Technology, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published May 23, 2025
Length 244 Pages
SKU # SPER20187034

Description

IVD In Cardiology and Neurology Market Introduction and Overview

According to SPER market research, ‘Global IVD In Cardiology and Neurology Market Size- By Product Type, By Technology, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global IVD In Cardiology and Neurology Market is predicted to reach 45.06 billion by 2034 with a CAGR of 9.69%.

In vitro diagnostic (IVD) in cardiology and neurology refers to medical tests performed on samples such as blood, urine, or tissue outside the body to identify cardiovascular and neurological problems. These tests are essential for detecting diseases such as heart disease, stroke, and Alzheimer’s, supporting early diagnosis, ongoing monitoring, and treatment plans. They provide important insights for patient care and improving outcomes.

Restraints:

The regulatory approach for IVD tests in cardiology and neurology can be complex and time-consuming. The expenses and resources required to achieve regulatory standards may divert focus and finances away from research and development activities, preventing the introduction of cutting-edge technology to meet changing diagnostic demands. The rigorous regulatory framework may impede market entry for certain firms, particularly those without the financial resources to negotiate the complex licensing processes.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Product Type, By Technology, By End-User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Sysmex Corp, Siemens Healthineers AG, Quest Diagnostics Inc, Abbott, BD, Bio-Rad Laboratories, Inc, Beckman Coulter, Inc.

Global IVD In Cardiology and Neurology Market Segmentation:

By Product Type: Based on the Product Type, Global IVD In Cardiology and Neurology Market is segmented as; Instruments, Reagents & Consumables, Software and Services.

By Technology:

Based on the Technology, Global IVD In Cardiology and Neurology Market is segmented as; Immunoassays, Molecular Diagnostics, Hematology, Others.

By End-User: Based on the End-User, Global IVD In Cardiology and Neurology Market is segmented as; Hospitals, Clinical Laboratories, Others.

By Region:

This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

244 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global IVD In Cardiology and Neurology Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global IVD In Cardiology and Neurology Market
7. Global IVD In Cardiology and Neurology Market, By Product Type (USD Million) 2021-2034
7.1. Instruments
7.2. Reagents & Consumables
7.3. Software and Services
8. Global IVD In Cardiology and Neurology Market, By Technology (USD Million) 2021-2034
8.1. Immunoassays
8.2. Molecular Diagnostics
8.3. Hematology
8.4. Others
9. Global IVD In Cardiology and Neurology Market, By End-User (USD Million) 2021-2034
9.1. Hospitals
9.2. Clinical Laboratories
9.3. Others
10. Global IVD In Cardiology and Neurology Market, (USD Million) 2021-2034
10.1. Global IVD In Cardiology and Neurology Market Size and Market Share
11. Global IVD In Cardiology and Neurology Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Thermo Fisher Scientific Inc
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. F. Hoffmann-La Roche Ltd
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Sysmex Corporation
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Siemens Healthineers AG
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Quest Diagnostics Incorporated
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Abbott
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. BD
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Bio-Rad Laboratories, Inc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Beckman Coulter, Inc
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.